<div id="readability-page-1">02:36 PM EST, 01/20/2026 (MT Newswires) -- Ardelyx ( ARDX ) may be acquired by Zydus Life, a pharmaceutical company publicly traded in India, CNBC TV18 reported Tuesday, citing sources.Zydus may buy a controlling stake in Waltham, Massachusetts-based Ardelyx ( ARDX ) or acquire certain assets and is raising funds via a qualified institutional placement, the report said.Ardelyx ( ARDX ) and Zydus didn't immediately respond to requests for comment from MT Newswires.Ardelyx ( ARDX ) shares rose 13% in Tuesday trading.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: 7.63, Change: +0.88, Percent Change: +12.96 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

IBBQ

HIND

RSLS

LABD

GLSI

Ardelyx (ARDX) may be acquired by Zydus Life, a publicly traded pharmaceutical company in India, according to CNBC TV18. Zydus is reportedly looking to buy a controlling stake in Ardelyx or certain assets and is raising funds through a qualified institutional placement. Ardelyx shares rose 13% in trading on the news. Both companies did not respond to requests for comment.

fidelity

VG Health

iShares Biotechnology ETF

VanEck Biotech ETF

Invesco Nasdaq Biotechnology ETF

Vyome

ReShape Lifesciences

Direxion S&P Biotech Bear 3X

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

Greenwich Lifesciences

Market Chatter: Ardelyx May Be Acquired by Zydus Life